Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation
- Conditions
- Intrauterine Growth Retardation
- Registration Number
- NCT00005105
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Brief Summary
OBJECTIVES:
I. Determine if mutations in the gene encoding the insulin-like growth factor-I receptor lead to relative insulin-like growth factor-I insensitivity and produce intrauterine growth retardation in children.
- Detailed Description
PROTOCOL OUTLINE:
Patients undergo blood draw. Insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) are measured. Patients whose IGF-I and IGFBP-3 levels are average or above are tested for the presence of mutation in the insulin-like growth factor-I receptor.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 75
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
Emory University School of Medicine
🇺🇸Atlanta, Georgia, United States
James Whitcomb Riley Hospital for Children
🇺🇸Indianapolis, Indiana, United States
Schneider Children's Hospital
🇺🇸New Hyde Park, New York, United States
Children's Hospital Medical Center - Cincinnati
🇺🇸Cincinnati, Ohio, United States
Medical College of Virginia School of Medicine
🇺🇸Richmond, Virginia, United States
Emory University School of Medicine🇺🇸Atlanta, Georgia, United States